Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: A prospective, two-year, single center, pilot study
Keywords: اینفیلیکسیماب; Adalimumab; Infliximab; Crohn's disease; Post-operative recurrence;